# Polypill for Prevention of Cardiomyopathy

> **NCT06143566** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Type 2 Diabetes
- High Blood Pressure

## Interventions

- **DRUG:** Polypill
- **DRUG:** Combined prescription of the individual medications

## Key facts

- **NCT ID:** NCT06143566
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-11
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143566, "Polypill for Prevention of Cardiomyopathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06143566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*